Adherence to treatment to help quit smoking: effects of task performance and coping with withdrawal symptoms

BMC Public Health

Reyes Rodríguez Tapioles²  Javier Machado Santiago²  Eva María López-Quirantes³  Maria Mar Rueda¹  Francisca López-Torrecillas³ 

[1] Universidad de Granada, Departamento de Estadística e Investigación Operativa, Granada, España;Universidad de Granada, Área de Medicina del Trabajo (Servicio de Prevención), Granada, España;Departamento de Personalidad, Evaluación y Tratamiento Psicológico, Centro de Investigación Cuerpo Cerebro Comportamiento (CIMCYC), Universidad de Granada, Campus Universitario de Cartuja s/n, 18071 Granada, España

关键词: Treatment adherence;    Treatment to quit smoking;   

Others  :  1122896
DOI  :  10.1186/1471-2458-14-1217

 received in 2014-02-23, accepted in 2014-11-10,  发布年份 2014

【 摘 要 】

Background

Currently the combined cognitive-behavioral and pharmacological treatment is the best option to quit smoking, although success rates remain moderate. This study aimed to identify predictors of continuous abstinence in an assisted smoking cessation program using combined treatment. In particular, we analyzed the effects of socio-demographic, smoking-, and treatment-related variables. In addition, we analyzed the effect of several risk factors on abstinence, and estimated a model of risk for smoking relapse.

Methods

Participants were 125 workers at the University of Granada (50 males), with an average age of 46.91 years (SD = 8.15). They were recruited between 2009 and 2013 at an occupational health clinic providing smoking cessation treatment. Baseline measures included socio-demographic data, preferred brand of cigarettes, number of years smoking, use of alcohol and/or tranquilizers, past attempts to quit, Fargerström Test for Nicotine Dependence, Smoking Processes of Change Scale, and Coping with Withdrawal Symptoms Interview. Participants were invited to a face-to-face assessment of smoking abstinence using self-report and cooximetry hemoglobin measures at 3, 6, and 12 months follow-up. The main outcome was smoking status coded as “relapse” versus “abstinence” at each follow-up. Kaplan-Meier survival analysis was performed to estimate the probability of continued abstinence during 12 months and log-rank tests were used to analyze differences in continued abstinence as a function of socio-demographic, smoking-, and treatment-related variables. Cox regression was used to analyze the simultaneous effect of several risk factors on abstinence.

Results

Using alcohol and/or tranquilizers was related to shorter abstinence. Physical exercise, the number of treatment sessions, performance of treatment tasks, and coping with withdrawal symptoms were related to prolonged abstinence. In particular, failure to perform the treatment tasks tripled the risk of relapse, while lack of coping doubled it.

Conclusions

Our results show that physical exercise, performance of treatment-related tasks, and effective coping with withdrawal symptoms can prolong abstinence from smoking. Programs designed to help quit smoking can benefit from the inclusion of these factors.

【 授权许可】

   
2014 López-Torrecillas et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Patwardhan P, McMillen R, Winickoff JP: Consumer perceptions of the sale of tobacco products in pharmacies and grocery stores among U.S. adults. BMC Res Notes 2013, 6:261-268. doi:10.1186/1756-0500-6-261 BioMed Central Full Text
• [2]ENSE: Ministry of Health: National Health Survey 2011-12. [http://www.msssi.gob.es/estadEstudios/estadisticas/docs/Sist.Salud.UE_2013.pdf webcite]
• [3]Japuntich SJ, Piper ME, Leventhal AM, Bolt DM, Baker TB: The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. J Consult Clin Psychol 2011, 79(1):34-42. doi:10.1037/a0022154
• [4]Secades-Villa R, Alonso-Perez F, Garcia-Rodriguez O, Fernandez-Hermida JR: Effectiveness of three intensities of smoking cessation treatment in primary care. Percept Mot Skills 2009, 105:747-758. doi:10.2466/pr0.105.3.747-758
• [5]Shiffman S, Brockwell SE, Pillitteri JL: Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics. Drug Alcohol Depend 2008, 93:121-131. doi:10.1016/j.drugalcdep.2007.09.005
• [6]Cahill K, Stevens S, Perera R, Lancaster T: Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013, 31(5):CD009329. doi:10.1002/14651858.CD009329.pub2
• [7]Ortega F, Vellisco A, Márquez E, López-Campos JL, Rodríguez A, de los Ángeles Sánchez M, Barrot E, Cejudo P: Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalized patients. Arch Bronconeumol 2011, 47(1):3-9. doi:10.1016/j.arbres.2010.07.007
• [8]Rigotti NA, Clair C, Munafò MR, Stead LF: Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2012, 16(5):CD001837. doi: 10.1002/14651858.CD001837.pub3
• [9]Agaku IT, King BA, Dube SR, EIS officer, CDC: Current cigarette smoking among adults - United States, 2005-2012. Morb Mortal Wkly Rep 2014, 63(2):29-34. PubMed PMID: 24430098
• [10]Bala MM, Strzeszynski L, Topor-Madry R, Cahill K: Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev 2013, 6(6):CD004704. doi: 10.1002/14651858.CD004704.pub3
• [11]Centers for Disease Control and Prevention (CDC): Cigarette smoking among adults--United States, 2007. MMWR Morb Mortal Wkly Rep 2008, 57(45):1221-1226. PMID: 19008790
• [12]Becoña E, Vázquez MI, Míguez MC, Fernández del Río E, López-Durán A, Martínez U, Piñeiro B: Smoking habit profile and health-related quality of life. Psicothema 2013, 25(4):421-426. doi: 10.7334/psicothema2013.73
• [13]Burgess DJ, Fu SS, Noorbaloochi S, Clothier BA, Ricards J, Widome R, van Ryn M: Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy. Nicotine Tob Res 2009, 11(12):1439-1447. doi:10.1093/ntr/ntp158
• [14]Ghani WM, Razak IA, Yang YH, Talib NA, Ikeda N, Axell T, Gupta PC, Handa Y, Abdullah N, Zain RB: Factors affecting commencement and cessation of smoking behaviour in Malaysian adults. BMC Public Health 2012, 19(12):207-219. doi:10.1186/1471-2458-12-207
• [15]Hagimoto A, Nakamura M, Morita T, Masui S, Oshima A: Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1-year follow-up study. Addiction 2010, 105(1):164-173. doi:10.1111/j.1360-0443.2009.02735.x
• [16]Meamar R, Etedali F, Sereshti N, Sabour E, Samani MD, Ardakani MR, Mirhosseini SM, Maracy M: Predictors of smoking cessation and duration: implication for smoking prevention. Int J Prev Med 2013, 4(2):194-200. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678217 webcite
• [17]Nerín I, Novella P, Beamonte A, Gargallo P, Jiménez-Muro A, Marqueta A: Results of smoking cessation therapy in a specialist unit. Arch Bronconeumol 2007, 43(12):669-673. doi:10.1157/13112965
• [18]Nordstrom BL, Kinnunen T, Utman CH, Krall EA, Vokonas PS, Garvey AJ: Predictors of continued smoking over 25 years of follow-up in the normative aging study. Am J Public Health 2000, 90(3):404-406. doi:10.1111/j.1758-5872.2012.00175.x
• [19]Ramos M, Ripoll J, Estrades T, Socias I, Fe A, Duro R, González MJ, Servera M: Effectiveness of intensive group and individual interventions for smoking cessation in primary health care settings: a randomized trial. BMC Public Health 2010, 23(10):89-99. doi:10.1186/1471-2458-10-89
• [20]Shiffman S: Reflections on smoking relapse research. Drug Alcohol Rev 2006, 25(1):15-20. PubMed PMID: 16492573
• [21]Silva GE, Galeano E, Correa JO: Adherencia al tratamiento. Acta Médica Colombiana 2005, 30:268-273. Available from: http://www.redalyc.org/articulo.oaid=163113820004 webcite
• [22]Balmford J, Borland R, Hammond D, Cummings KM: Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res 2011, 13(2):94-102. doi:10.1093/ntr/ntq215
• [23]Prochaska JJ, Hall SM, Humfleet G, Munoz RF, Reus V, Gorecki J, Hu D: Physical activity as a strategy for maintaining tobacco abstinence: a randomized trial. Prev Med 2008, 47(2):215-220. doi:10.1016/j.ypmed.2008.05.006
• [24]Scioli ER, Biller H, Rossi J, Riebe D: Personal motivation, exercise and smoking behaviors among young adults. Behav Med 2009, 35(2):57-64. doi:10.3200/BMED. 35.2.57-66
• [25]Zhang L, Samet J, Caffo B, Bankman I, Punjabi NM: Power spectral analysis of EEG activity during sleep in cigarette smokers. Chest 2008, 133(2):427-432. PubMed PMID: 17925420
• [26]Roberts V, Maddison R, Simpson C, Bullen C, Prapavessis H: The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect, and smoking behaviour: systematic review update and meta-analysis. Psychopharmacology 2012, 222(1):1-15. doi:10.1007/s00213-012-2731-z
• [27]Heckman BW, Kovacs MA, Marquinez NS, Meltzer LR, Tsambarlis ME, Drobes DJ, Brandon TH: Influence of affective manipulations on cigarette craving: a meta-analysis. Addiction 2013, 108(12):2068-2078. doi:10.1111/add.12284
• [28]Consejería para la Igualdad y Bienestar Social: Junta de Andalucía Guía de Practica Clínica de Adicción al Tabaco. 2008. Available: http://www.dipgra.es/documentos/guia_clinica_tabaco.pdf webcite
• [29]U.S. Food And Drug Administration: New Drug for Smoking Cessation. 2004. Available: http://www.scribd.com/doc/220707857/VARENICLINA webcite
• [30]Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003, 5:13-25.
• [31]Fu SS, van Ryn M, Sherman SE, Burgess DJ, Noorbaloochi S, Clothier B, Joseph AM: Population-based tobacco treatment: study design of a randomized controlled trial. BMC Public Health 2012, 6:12-159. doi:10.1186/1471-2458-12-159
• [32]Lindqvist H, Forsberg LG, Forsberg L, Rosendahl I, Enebrink P, Helgason AR: Motivational interviewing in an ordinary clinical setting: a controlled clinical trial at the Swedish National Tobacco Quitline. Addict Behav 2013, 38(7):2321-2324. doi:10.1016/j.addbeh.2013.03.002
• [33]López-Torrecillas F: Estrés, afrontamiento, variables de personalidad y consumo de drogas. Departamento de Personalidad, Evaluación y Tratamiento Psicológico: Universidad de Granada; 1995. [PhD thesis doctoral]
• [34]Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K: The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J of Addic 1991, 86:1119-1127.
• [35]De Leon J, Becoña E, Gurpegui M, González-Pinto A, Diaz FJ: The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry 2002, 63:812-816.
• [36]Becoña E, Vázquez FL: The Fagerström Test for Nicotine Dependence in a Spanish sample. Psychol Rep 1998, 83:1455-1458.
• [37]DiClemente CC, Prochaska JO: Processes and stages of change: Coping and competence in smoking behavior change. In Coping and Substance Abuse. Edited by Shiffman S, Wills TA. New York: Academic Press; 1985:319-343.
• [38]Prochaska JO, Velicer WF, DiClemente CC, Fava J: Measuring processes of change: application to the cessation of smoking. J Consult Clin Psychol 1988, 56:520-528.
• [39]Tejero A, Trujols J: El modelo transteorético de Prochaska y Diclemente: un modelo dinámico de cambio en el ámbito de las conductas adictivas. In Conductas Adictivas. Edited by Graña JL. Madrid: Debate; 1994. 3-43
• [40]Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35(8):1381-1395. PMID: 12900694
• [41]Delgado M, Tercedor P, Soto VM: Cuestionario Internacional de Actividad Física (IPAQ). http://www.juntadeandalucia.es/salud webcite
• [42]Curry S, Marlatt GA, Peterson AV, Lutton J: Survival analysis and assessment of relapse rates. In Assessment of Addictive Behaviors. Edited by Donevan DM, Marlatt GA. New York, NY: Guilford Press; 1988:454-473.
• [43]Kleinbaum DG, Klein M: Survival Analysis. A Self-learning Text. New York: Springer; 2005.
• [44]Willett JB, Singer JD: Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence. J Consult Clin Psych 1993, 61:952-965.
• [45]Cox DR: Regression model and life tables. J R Stat Soc 1972, 34:187-220.
• [46]Cox DR, Oakes D: The Analysis of Survival Data. Londres: Chapman and Hall; 1984.